Cell Culture Media Market is likely to expand at a CAGR of 7.0% from 2023 to 2033

The cell culture media market is predicted to be worth US$ 3.3 billion in 2023, rising to US$ 6.4 billion by 2033. Cell culture media sales are predicted to grow at a substantial CAGR of 7.0% during the forecast period.

The development, production, and research of biopharmaceuticals are all based on the culture media. In biopharmaceutical research, cell culture media are employed at all stages of the drug development process, from discovery to manufacturing.

Biologics are gaining popularity, which has caused the market for culture media to expand significantly because scientists need media to make their work viable. Additionally, the market is expanding due to the rising demand for vaccines against various diseases.

Get Sample PDF@ https://www.futuremarketinsights.com/reports/sample/rep-gb-14366

The global prevalence of chronic diseases is significantly increasing. Lifestyle changes and an aging population are the primary contributors to an increase in the rates of chronic diseases. As a result, the demand for effective chronic disease treatment is driving the adoption of culture media.

Infrastructure growth, technological development, and modernization of the healthcare sector around the world and an increase in diagnostic labs would help the market for cultured media to expand.

The market is anticipated to rise as a result of increased research efforts in areas like cancer, stem cells, biopharmaceuticals, and others, as well as higher spending on research and development.

However, it is also estimated that a shortage of qualified specialists with ethical and scientific concerns may restrain industry expansion. On the other hand, the market for culture media is predicted to see plenty of prospects due to untapped potential in developing countries and innovation in the media.

Key Takeaways from Market Study

  • Serum-free media witnessed a significant growth of 6.9% in terms of CAGR rate. The usage of SFM denotes an important tool that enables researchers to carry out specific applications or develop a certain cell type without the need for serum.
  • during the forecast period, the category for cancer research is expected to develop at a prominent CAGR of 7.5%. The growth of the cancer research segment is anticipated to be driven by increasing biologics research and development activities and the growing need for vaccine production.
  • With a revenue share of more than US$ 1.9 billion in 2023, the United States market holds a strong position in the global market. One of the main factors fuelling the market’s expansion is the existence of a sizable number of companies. Since the pharmaceutical business is more research-intensive, there is a great need for cultural media there.
  • China is the most profitable region among others growing at an astonishing rate of 9.0% over the analysis period. Due to rising investments in the pharmaceutical and biopharmaceutical industries, China regional market is anticipated to develop at a great rate over the forecast period.

Talk to Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-14366

Competitive Landscape:

To increase their market position, key players in this sector are using a variety of techniques, such as partnerships through mergers and acquisitions, geographic growth, and strategic collaborations. For instance, in July 2021, Sartorius purchased Xell AG, a leader in cell culture, through its subsidiary Sartorius Stedim Biotech. The business creates, manufactures, and sells feed additives and media for cell cultures, primarily for the production of viral vectors used in vaccine and gene therapy production.

Latest Developments:

  • Captivate Bio introduced its line of cell culture tools in January 2021 to help in the fight against COVID-19 and other new diseases.
  • Chemovator GmbH introduced its first product line, BIOFLOAT, in May 2020. This line consists of surface coatings for cell culture consumables.

Key Segments

By Type:

  • Serum-free Media
  • CHO Media
  • HEK 293 Media
  • BHK Media
  • VERO Cell Media
    • Insect Cell Media
    • Serum-free Stem Cell Media
    • CAR T-cell Media
    • Other Serum-free Media
    • Classical Media & Salts
    • Stem Cell Culture Media
    • Specialty Media
    • Chemically defined Media
    • Other Cell Culture Media

By Application:

  • Biopharmaceutical Production
  • Monoclonal antibodies
  • Vaccines production
  • Other therapeutic proteins
    • Diagnostics
    • Drug Screening & Development
    • Tissue Engineering & Regenerative Medicine
    • Cell and gene therapy
    • Other tissue engineering & regenerative medicine applications
    • Other Application

By End User:

  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostic Laboratories
  • Research & Academic Institutes
  • Others

Buy Complete Report@ https://www.futuremarketinsights.com/checkout/14366

About Future Market Insights (FMI)

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedInTwitterBlogs

About the Author

Nikhil Kaitwade

Associate Vice President at Future Market Insights, Inc. has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.
His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.
Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like these